Arterial Thrombosis – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Arterial Thrombosis – Drugs In Development, 2024 report and make more profitable business decisions.
Arterial thrombosis is a blood clot that develops in an artery. Symptoms include lack of pulse, pain or spasms in the muscles, pale skin, and coldness. Depending on where the clot forms, arterial thrombosis can cause several serious conditions, including stroke, heart attack, and peripheral arterial disease (PAD). Predisposing factors include smoking, obesity, diabetes, hypertension, and high cholesterol level. Treatment includes thrombolytic agents and surgery.
The Arterial Thrombosis drugs in development market research report provide comprehensive information on the therapeutics under development for Arterial Thrombosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Arterial Thrombosis and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Arterial Thrombosis | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 13 molecules, with 9 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Arterial Thrombosis therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Arterial Thrombosis pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Arterial Thrombosis treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Astellas Pharma IncCentral Drug Research Institute
Cereno Scientific AB
GLSynthesis Inc
Jiangsu Hengrui Medicine Co Ltd
MDI Therapeutics Inc
Oasis Pharmaceuticals LLC
Protheragen Inc
University of Liege
University of Pennsylvania
Virginia Commonwealth University
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Arterial Thrombosis reports